image
Corvus Pharmaceuticals, Inc. CRVS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.19
-3.87 %
$ 526 M
Market Cap
-19.98
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 0.00% 45.99% 28.36%
Annual Report FY 10-K 2022-12-31 0.00% -31.02% 15.70%
Annual Report FY 10-K 2021-12-31 0.00% -692.04% 11.72%
Annual Report FY 10-K 2020-12-31 0.00% 88.98% 10.43%
Annual Report FY 10-K 2019-12-31 0.00% 6.80% 0.75%
Annual Report FY 10-K 2018-12-31 0.00% 15.67% 12.92%
Annual Report FY 10-K 2017-12-31 0.00% -53.03% -52.87%
Annual Report FY 10-K 2016-12-31 0.00% -16.08% -168.53%
Annual Report FY 10-K 2015-12-31 0.00% -17740.88% -7740.08%
Annual Report FY 10-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -570.28% -30.49%
Quarterly Report Q2 8-K 2024-06-30 0.00% 34.46% -5.57%
Quarterly Report Q1 8-K 2024-03-31 0.00% 35.19% 4.88%
Quarterly Report Q4 8-K 2023-12-31 0.00% 58.93% 0.26%
Quarterly Report Q3 8-K 2023-09-30 0.00% 59.54% 55.42%
Quarterly Report Q2 8-K 2023-06-30 0.00% 21.30% 19.83%
Quarterly Report Q1 8-K 2023-03-31 0.00% 4.19% 11.32%
Quarterly Report Q4 8-K 2022-12-31 0.00% -75.40% 16.80%
Quarterly Report Q3 8-K 2022-09-30 0.00% -38.96% -37.87%
Quarterly Report Q2 8-K 2022-06-30 0.00% 29.69% 37.88%
Quarterly Report Q1 8-K 2022-03-31 0.00% 20.72% 35.44%
Quarterly Report Q4 8-K 2021-12-31 0.00% -33.77% 31.07%
Quarterly Report Q3 8-K 2021-09-30 0.00% -8.95% 8.11%
Quarterly Report Q2 8-K 2021-06-30 0.00% -10.75% -4.86%
Quarterly Report Q1 8-K 2021-03-31 0.00% 10.48% 13.46%
Quarterly Report Q4 8-K 2020-12-31 0.00% 347.55% 13.65%
Quarterly Report Q3 8-K 2020-09-30 0.00% 10.98% 14.49%
Quarterly Report Q2 8-K 2020-06-30 0.00% 18.24% 20.81%
Quarterly Report Q1 8-K 2020-03-31 0.00% -11.10% -7.83%
Quarterly Report Q4 8-K 2019-12-31 0.00% -5.12% -2.41%
Quarterly Report Q3 8-K 2019-09-30 0.00% -4.82% -3.26%
Quarterly Report Q2 8-K 2019-06-30 0.00% -11.58% -10.92%
Quarterly Report Q1 8-K 2019-03-31 0.00% 18.59% 15.97%
Quarterly Report Q4 8-K 2018-12-31 0.00% 11.90% 8.35%
Quarterly Report Q3 8-K 2018-09-30 0.00% 17.45% 13.87%
Quarterly Report Q2 8-K 2018-06-30 0.00% 22.36% 19.22%
Quarterly Report Q1 8-K 2018-03-31 0.00% 10.82% 9.70%
Quarterly Report Q4 8-K 2017-12-31 0.00% -7.60% -8.36%
Quarterly Report Q3 8-K 2017-09-30 0.00% -23.50% -23.56%
Quarterly Report Q2 8-K 2017-06-30 0.00% -73.29% -71.94%
Quarterly Report Q1 8-K 2017-03-31 0.00% -152.65% -152.37%
Quarterly Report Q4 8-K 2016-12-31 0.00% -83.57% -84.29%
Quarterly Report Q3 8-K 2016-09-30 0.00% -226.79% -235.77%
Quarterly Report Q2 8-K 2016-06-30 0.00% 57.27% -278.43%
Quarterly Report Q1 8-K 2016-03-31 0.00% -231.78% -190.24%
Quarterly Report Q4 8-K 2015-12-31 0.00% -3830.72% -3873.03%
Quarterly Report Q3 8-K 2015-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2015-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2015-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%